News
Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...
New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.
New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a ...
This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...
New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a ...
OSE Immunotherapeutics. OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies. OSE ...
OSE Immunotherapeutics partners with Inside Therapeutics & MiNT Laboratory to develop mRNA therapeutics and accelerate nanodrug development: Nantes, France Saturday, May 24, 2025, ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a delivery system for ...
Although liquid chromatography/mass spectrometry using selected reaction monitoring (LC/SRM-MS) holds great promise for targeted protein analysis, quantification of therapeutic monoclonal antibody ...
Until recently, scientists believed antibodies couldn't safely target lipids without risking harm to healthy tissues, since the same lipids that appear in viruses are widely distributed throughout ...
Engineering an antibody against flu with sticky staying power Aerosol treatment adheres to lung lining, blocks infection in mice Date: May 8, 2025 Source: Ohio State University Summary: Scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results